SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Braveheart Bio to Host HCM Webinar on November 6

Braveheart Bio said it will host an investor webinar on hypertrophic cardiomyopathy, featuring a key opinion leader discussion. The company describes itself as developing therapies for HCM and other cardiovascular diseases.

BRVE

Related stories